date,text,form,accepted_time
2020-06-29," 8-k 1 eh2000886_8k.htm form 8-k united states securities and exchange commission washington, d.c. 20549 _________________ form 8-k _________________ current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of report (date of earliest event reported): june 26, 2020 _________________ churchill capital corp ii (exact name of registrant as specified in its charter) _________________ delaware 001-38960 83-4388331 (state or other jurisdiction of incorporation) (commission file number) (i.r.s. employer identification no.) 640 fifth avenue, 12th floor new york, ny 10019 (address of principal executive offices) (zip code) (212) 380-7500 (registrant’s telephone number, including area code) not applicable (former name or former address, if changed since last report) _________________ check the appropriate box below if the form 8-k is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ written communication pursuant to rule 425 under the securities act (17 cfr 230.425) ☐ soliciting material pursuant to rule 14a-12 under the exchange act (17 cfr 240.14a-12) ☐ pre-commencement communications pursuant to rule 14d-2(b) under the exchange act (17 cfr 240.14d-2(b)) ☐ pre-commencements communications pursuant to rule 13e-4(c) under the exchange act (17 cfr 240.13e-4(c)) securities registered pursuant to section 12(b) of the act: title of each class trading symbol(s) name of each exchange on which registered units, each consisting of one share of class a common stock, $0.0001 par value, and one-third of one warrant ccx.u new york stock exchange shares of class a common stock ccx new york stock exchange warrants ccx ws new york stock exchange indicate by check mark whether the registrant is an emerging growth company as defined in rule 405 of the securities act of 1933 (§230.405 of this chapter) or rule 12b-2 of the securities exchange act of 1934 (§240.12b-2 of this chapter). emerging growth company ☒ if an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the exchange act. ☐ item 5.02 departure of directors or principal officers; election of directors; appointment of principal officers; compensatory arrangements of certain officers. effective june 26, 2020, the board of directors (the “board”) of churchill capital corp ii (the “company”) appointed dena brumpton as a director of the company. ms. brumpton will serve as a class iii director of the company with a term expiring at the company’s third annual meeting of stockholders following the company’s initial public offering. ms. brumpton will serve on the audit committee of the board. ms. brumpton is currently a non-executive director of leathwaite human capital limited, non-executive director of scottish widows schroder wealth holdings limited where she chairs the audit and risk committees in addition to being a member of the remuneration committee and non-executive director of maitland international holdings limited. previously, she was the ceo for barclays savings, investments and wealth management. prior to barclays, over the course of thirty years, ms. brumpton held various roles at citigroup where she held several senior leadership positions in asset management, corporate and investment banking and most recently private banking and wealth management, where she was global chief operating officer for the private bank. in connection with her election to the board, ms. brumpton will enter into an indemnification agreement with the company pursuant to which the company will agree to indemnify her from certain liabilities that may arise by reason of her status as a director and advance certain expenses incurred by her. the form of indemnification agreement was filed as exhibit 10.7 to the registration statement on form s-1, filed with the securities and exchange commission (the “sec”) on june 10, 2019. ms. brumpton will also enter into a letter agreement among churchill sponsor ii llc and the company’s officers and directors, and this agreement waives certain redemption rights and certain rights to liquidating distributions from the trust account. the form of letter agreement was filed as exhibit 10.2 to the registration statement on form s-1, filed with the securities and exchange commission on june 10, 2019. 2 signature pursuant to the requirements of the securities exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. churchill capital corp ii date: june 29, 2020 by: /s/ peter seibold name: peter seibold title: chief financial officer 3 ",8-K,2020-06-29 16:02:07
2019-10-23," 8-k 1 eh1901174_8k.htm form 8-k united states securities and exchange commission washington, d.c. 20549 _________________ form 8-k _________________ current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of report (date of earliest event reported): october 23, 2019 _________________ churchill capital corp ii (exact name of registrant as specified in its charter) _________________ delaware 001-38960 83-4388331 (state or other jurisdiction of incorporation) (commission file number) (i.r.s. employer identification no.) 640 fifth avenue, 12th floor new york, ny 10019 (address of principal executive offices) (zip code) (212) 380-7500 (registrant’s telephone number, including area code) not applicable (former name or former address, if changed since last report) _________________ check the appropriate box below if the form 8-k is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ written communication pursuant to rule 425 under the securities act (17 cfr 230.425) ☐ soliciting material pursuant to rule 14a-12 under the exchange act (17 cfr 240.14a-12) ☐ pre-commencement communications pursuant to rule 14d-2(b) under the exchange act (17 cfr 240.14d-2(b)) ☐ pre-commencements communications pursuant to rule 13e-4(c) under the exchange act (17 cfr 240.13e-4(c)) securities registered pursuant to section 12(b) of the act: title of each class trading symbol(s) name of each exchange on which registered units, each consisting of one share of class a common stock, $0.0001 par value, and one-third of one warrant ccx.u new york stock exchange shares of class a common stock ccx new york stock exchange warrants ccx ws new york stock exchange indicate by check mark whether the registrant is an emerging growth company as defined in rule 405 of the securities act of 1933 (§230.405 of this chapter) or rule 12b-2 of the securities exchange act of 1934 (§240.12b-2 of this chapter). emerging growth company ☒ if an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the exchange act. ☐ item 5.02 departure of directors or principal officers; election of directors; appointment of principal officers; compensatory arrangements of certain officers. effective october 23, 2019, the board of directors (the “board”) of churchill capital corp ii (the “company”) appointed jeremy abson as a director of the company. mr. abson will serve as a class iii director. mr. abson is currently the president and chief financial officer of tbg ag, an investment company. he holds a bachelor of science degree from manchester university, united kingdom, and is a member of the institute of chartered accountants in england and wales. he completed the advanced management program at the harvard business school in october 2011. he has more than 20 years of experience in financial and general management. prior to joining tgb ag, mr. abson was the chief operating officer of usaha tegas sdn bhd, a multi-billion investment company which had significant interests in the telecommunications, media, power, energy, marine logistics and real estate sectors. prior to that, he was a partner at pricewaterhousecoopers. in connection with his election to the board, mr. abson will enter into an indemnification agreement with the company pursuant to which the company will agree to indemnify him from certain liabilities that may arise by reason of his status as a director and advance certain expenses incurred by him. the form of indemnification agreement was filed as exhibit 10.7 to the registration statement on form s-1, filed with the securities and exchange commission (the “sec”) on june 10, 2019. mr. abson will also enter into a letter agreement among churchill sponsor ii llc and the company’s officers and directors, and this agreement waives certain redemption rights and certain rights to liquidating distributions from the trust account. the form of letter agreement was filed as exhibit 10.2 to the registration statement on form s-1, filed with the securities and exchange commission on june 10, 2019. signature pursuant to the requirements of the securities exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. churchill capital corp ii date: october 23, 2019 by: /s/ peter seibold name: peter seibold title: chief financial officer ",8-K,2019-10-23 08:00:43
2019-07-23," 8-k 1 eh1900925_8k.htm form 8-k united states securities and exchange commission washington, d.c. 20549 _________________ form 8-k _________________ current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of report (date of earliest event reported): july 23, 2019 _________________ churchill capital corp ii (exact name of registrant as specified in its charter) _________________ delaware 001-38960 83-4388331 (state or other jurisdiction of incorporation) (commission file number) (i.r.s. employer identification no.) 640 fifth avenue, 12th floor new york, ny 10019 (address of principal executive offices) (zip code) (212) 380-7500 (registrant’s telephone number, including area code) not applicable (former name or former address, if changed since last report) _________________ check the appropriate box below if the form 8-k is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ written communication pursuant to rule 425 under the securities act (17 cfr 230.425) ☐ soliciting material pursuant to rule 14a-12 under the exchange act (17 cfr 240.14a-12) ☐ pre-commencement communications pursuant to rule 14d-2(b) under the exchange act (17 cfr 240.14d-2(b)) ☐ pre-commencements communications pursuant to rule 13e-4(c) under the exchange act (17 cfr 240.13e-4(c)) securities registered pursuant to section 12(b) of the act: title of each class trading symbol(s) name of each exchange on which registered units, each consisting of one share of class a common stock, $0.0001 par value, and one-third of one warrant ccx.u new york stock exchange shares of class a common stock ccx new york stock exchange warrants ccx ws new york stock exchange indicate by check mark whether the registrant is an emerging growth company as defined in rule 405 of the securities act of 1933 (§230.405 of this chapter) or rule 12b-2 of the securities exchange act of 1934 (§240.12b-2 of this chapter). emerging growth company ☒ if an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the exchange act. ☐ item 8.01 other events. on july 23, 2019, churchill capital corp ii (the “company”) issued a press release, a copy of which is attached as exhibit 99.1 to this current report on form 8-k, announcing that the holders of the company’s units may elect to separately trade the class a ordinary shares and warrants comprising the units commencing on july 26, 2019. those units not separated will continue to trade on the new york stock exchange under the symbol “ccx.u,” and each of the class a ordinary shares and warrants that are separated will trade on the new york stock exchange under the symbols “ccx” and “ccx ws,” respectively. item 9.01 financial statements and exhibits. (d) exhibits. the following exhibits are filed with this form 8-k: exhibit no. description of exhibits 99.1 press release dated july 23, 2019 signature pursuant to the requirements of the securities exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. churchill capital corp ii date: july 23, 2019 by: /s/ peter seibold name: peter seibold title: chief financial officer ",8-K,2019-07-23 16:56:26
2019-07-08," 8-k 1 tv524862_8k.htm form 8-k united states securities and exchange commission washington, d.c. 20549 _________________ form 8-k _________________ current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of report (date of earliest event reported): july 1, 2019 _________________ churchill capital corp ii (exact name of registrant as specified in its charter) _________________ delaware 001-38960 83-4388331 (state or other jurisdiction of incorporation) (commission file number) (i.r.s. employer identification no.) 640 fifth avenue, 12th floor new york, ny 10019 (address of principal executive offices) (zip code) (212) 380-7500 (registrant’s telephone number, including area code) not applicable (former name or former address, if changed since last report) _________________ check the appropriate box below if the form 8-k is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨written communication pursuant to rule 425 under the securities act (17 cfr 230.425) ¨soliciting material pursuant to rule 14a-12 under the exchange act (17 cfr 240.14a-12) ¨pre-commencement communications pursuant to rule 14d-2(b) under the exchange act (17 cfr 240.14d-2(b)) ¨pre-commencements communications pursuant to rule 13e-4(c) under the exchange act (17 cfr 240.13e-4(c)) securities registered pursuant to section 12(b) of the act: title of each class trading symbol(s) name of each exchange on which registered units, each consisting of one share of class a common stock, $0.0001 par value, and one-third of one warrant ccx.u new york stock exchange shares of class a common stock ccx new york stock exchange warrants included as part of the units ccx ws new york stock exchange indicate by check mark whether the registrant is an emerging growth company as defined in rule 405 of the securities act of 1933 (§230.405 of this chapter) or rule 12b-2 of the securities exchange act of 1934 (§240.12b-2 of this chapter). emerging growth company x if an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the exchange act. ¨ item 8.01other events. on july 1, 2019, churchill capital corp ii (the “company”) consummated its initial public offering (the “ipo”) of 69,000,000 units (the “units”), including the issuance of 9,000,000 units as a result of the underwriters’ exercise of their over-allotment option. each unit consists of one share of the company’s class a common stock, par value $0.0001 per share (the “class a common stock”), and one-third of one warrant of the company (the “warrants”), each whole warrant entitling the holder thereof to purchase one whole share of class a common stock at a price of $11.50 per share, subject to adjustment as provided in the company’s registration statement on form s-1, initially filed with the securities and exchange commission on june 10, 2019 (file no. 333-232057). the units were sold at a price of $10.00 per unit, generating gross proceeds to the company of $690,000,000. simultaneously with the closing of the ipo, the company completed the private sale (the “private placement”) of an aggregate of 15,800,000 warrants (the “private placement warrants”) at a purchase price of $1.00 per private placement warrant, to the company’s sponsor, churchill sponsor ii llc (the “sponsor”), generating gross proceeds to the company of $15,800,000. the private placement warrants are identical to the warrants sold as part of the units in the ipo, except that the sponsor has agreed not to transfer, assign or sell any of the private placement warrants (except to certain permitted transferees) until 30 days after the completion of the company’s initial business combination. the private placement warrants are also not redeemable by the company so long as they are held by the sponsor or its permitted transferees. a total of $690,000,000 was placed in a u.s.-based trust account at j.p. morgan chase bank, n.a. with continental stock transfer & trust company acting as trustee. an audited balance sheet as of july 1, 2019 reflecting receipt of the proceeds upon consummation of the ipo and the private placement has been issued by the company and is included as exhibit 99.1 to this current report on form 8-k. item 9.01financial statements and exhibits. (d) exhibits. the following exhibits are filed with this form 8-k: exhibit no. description of exhibits 99.1 audited balanced sheet as of july 1, 2019 2 signature pursuant to the requirements of the securities exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. churchill capital corp ii date: july 8, 2019 by: /s/ peter seibold name: peter seibold title: chief financial officer 3 ",8-K,2019-07-08 17:24:49
2019-07-02," 8-k 1 tv524635_8k.htm form 8-k united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15(d) of the securities exchange act of 1934 date of report (date of earliest event reported): june 26, 2019 churchill capital corp ii (exact name of registrant as specified in its charter) delaware 001-38960 83-4388331 (state or other jurisdiction of incorporation) (commission file number) (i.r.s. employer identification no.) 640 fifth avenue, 12th floor new york, ny 10019 (address of principal executive offices) (zip code) (212) 380-7500 (registrant’s telephone number, including area code) not applicable (former name or former address, if changed since last report) check the appropriate box below if the form 8-k is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨written communication pursuant to rule 425 under the securities act (17 cfr 230.425) ¨soliciting material pursuant to rule 14a-12 under the exchange act (17 cfr 240.14a-12) ¨pre-commencement communications pursuant to rule 14d-2(b) under the exchange act (17 cfr 240.14d-2(b)) ¨pre-commencements communications pursuant to rule 13e-4(c) under the exchange act (17 cfr 240.13e-4(c)) securities registered pursuant to section 12(b) of the act: title of each class trading symbol(s) name of each exchange on which registered units, each consisting of one share of new york stock exchange class a common stock, ccx.u $0.0001 par value, and one-third of one warrant shares of class a common stock ccx new york stock exchange warrants included as part of the units ccx ws new york stock exchange indicate by check mark whether the registrant is an emerging growth company as defined in rule 405 of the securities act of 1933 (§230.405 of this chapter) or rule 12b-2 of the securities exchange act of 1934 (§240.12b-2 of this chapter). emerging growth company x if an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the exchange act. ¨ item 8.01other events. on july 1, 2019, churchill capital corp ii (the “company”) consummated its initial public offering (the “ipo”) of 69,000,000 units (the “units”), including the issuance of 9,000,000 units as a result of the underwriters’ exercise of their over-allotment option. each unit consists of one share of the company’s class a common stock, par value $0.0001 per share (the “class a common stock”), and one-third of one warrant of the company (the “warrants”), each whole warrant entitling the holder thereof to purchase one whole share of class a common stock at a price of $11.50 per share, subject to adjustment as provided in the company’s registration statement on form s-1, initially filed with the securities and exchange commission on june 10, 2019 (file no. 333-232057). the units were sold at a price of $10.00 per unit, generating gross proceeds to the company of $690,000,000. simultaneously with the closing of the ipo, the company completed the private sale (the “private placement”) of an aggregate of 15,800,000 warrants (the “private placement warrants”) at a purchase price of $1.00 per private placement warrant, to the company’s sponsor, churchill sponsor ii llc (the “sponsor”), generating gross proceeds to the company of $15,800,000. the private placement warrants are identical to the warrants sold as part of the units in the ipo, except that the sponsor has agreed not to transfer, assign or sell any of the private placement warrants (except to certain permitted transferees) until 30 days after the completion of the company’s initial business combination. the private placement warrants are also not redeemable by the company so long as they are held by the sponsor or its permitted transferees. a total of $690,000,000 was placed in a u.s.-based trust account at j.p. morgan chase bank, n.a. with continental stock transfer & trust company acting as trustee. except with respect to interest earned on the funds in the trust account that may be released to the company to pay its taxes, the proceeds from the ipo will not be released from the trust account until the earliest of (i) the completion of the company’s initial business combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the company’s amended and restated certificate of incorporation to modify the substance or timing of its obligation to provide for the redemption of its public shares in connection with an initial business combination or to redeem 100% of its public shares if the company does not complete its initial business combination within 24 months from the closing of the ipo (or 27 months from the closing of the ipo if the company has executed a letter of intent, agreement in principle or definitive agreement for an initial business combination within 24 months from the closing of the ipo), and (iii) the redemption of all of the company’s public shares if it is unable to complete its business combination within 24 months (or 27 months upon the satisfaction of the conditions set forth in (ii)) from the closing of the ipo, subject to applicable law. in connection with the closing of the offering, the company entered into an amendment to the underwriting agreement on july 1, 2019 pursuant to which the underwriting discount will be paid solely with respect to 1,060,000 of the shares sold pursuant to the overallotment option. as a result, the deferred portion of the underwriting discount will be $21,371,000 and the company will have an additional $1,588,000 available for working capital held outside the trust account. in connection with the ipo, the company also entered into the following agreements previously filed as exhibits to the company’s registration statement: ·an underwriting agreement, dated june 26, 2019, among the company and citigroup global markets inc., as representative of the underwriters. ·a warrant agreement, dated june 26, 2019, between the company and continental stock transfer & trust company, as warrant agent. 2 ·a letter agreement, dated june 26, 2019, among the company, its officers and directors and the sponsor. ·an investment management trust agreement, dated june 26, 2019, between the company and continental stock transfer & trust company, as trustee. ·a registration rights agreement, dated june 26, 2019, among the company and certain other security holders named therein. ·a private placement warrant purchase agreement, dated june 26, 2019, between the company and the sponsor. ·an indemnity agreement, dated june 26, 2019, between the company and michael klein. ·an indemnity agreement, dated june 26, 2019, between the company and peter seibold. ·an indemnity agreement, dated june 26, 2019, between the company and mark klein. ·an indemnity agreement, dated june 26, 2019, between the company and malcolm s. mcdermid. ·an indemnity agreement, dated june 26, 2019, between the company and glenn august. ·an indemnity agreement, dated june 26, 2019, between the company and karen g. mills. ·an administrative services agreement, dated june 26, 2019, between the company and an affiliate of the sponsor. item 9.01financial statements and exhibits. (d)exhibits. the following exhibits are filed with this form 8-k: exhibit no. description of exhibits 1.1 underwriting agreement, dated june 26, 2019, among the company and citigroup global markets inc., as representative of the underwriters. 1.2 amendment to the underwriting agreement, dated july 1, 2019, among the company and citigroup global markets inc., as representative of the underwriters. 4.1 warrant agreement, dated june 26, 2019, between the company and continental stock transfer & trust company, as warrant agent. 10.1 letter agreement, dated june 26, 2019, among the company, its officers and directors and the sponsor. 10.2 investment management trust agreement, dated june 26, 2019, between the company and continental stock transfer & trust company, as trustee. 10.3 registration rights agreement, dated june 26, 2019, among the company and certain other security holders named therein. 10.4 private placement warrant purchase agreement, dated june 26, 2019, between the company and the sponsor. 10.5 indemnity agreement, dated june 26, 2019, between the company and michael klein. 3 exhibit no. description of exhibits 10.6 indemnity agreement, dated june 26, 2019, between the company and peter seibold. 10.7 indemnity agreement, dated june 26, 2019, between the company and mark klein. 10.8 indemnity agreement, dated june 26, 2019, between the company and malcolm s. mcdermid. 10.9 indemnity agreement, dated june 26, 2019, between the company and glenn august. 10.10 indemnity agreement, dated june 26, 2019, between the company and karen g. mills. 10.11 administrative services agreement, dated june 26, 2019, between the company and an affiliate of the sponsor. 4 signature pursuant to the requirements of the securities exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. churchill capital corp ii date: july 2, 2019 by: /s/ peter seibold name: peter seibold title: chief financial officer 5 ",8-K,2019-07-02 17:27:56
